Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,360 hedge funds and large institutions have $43.1B invested in Celgene Corp in 2018 Q2 according to their latest regulatory filings, with 100 funds opening new positions, 443 increasing their positions, 651 reducing their positions, and 125 closing their positions.
3% less funds holding
Funds holding: 1,397 → 1,360 (-37)
7% less funds holding in top 10
Funds holding in top 10: 42 → 39 (-3)
14% less capital invested
Capital invested by funds: $49.9B → $43.1B (-$6.86B)
17% less call options, than puts
Call options by funds: $1.82B | Put options by funds: $2.2B
20% less first-time investments, than exits
New positions opened: 100 | Existing positions closed: 125
32% less repeat investments, than reductions
Existing positions increased: 443 | Existing positions reduced: 651
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
HBK Investments
Dallas,
Texas
|
+$1.29B |
| 2 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$320M |
| 3 |
Edgewood Management
Greenwich,
Connecticut
|
+$161M |
| 4 |
Renaissance Technologies
New York
|
+$129M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$128M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$342M |
| 2 |
Goldman Sachs
New York
|
-$298M |
| 3 |
Jennison Associates
New York
|
-$273M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$262M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$244M |
CELG Hedge Fund Activity: Q2 2018 in Review
1,360 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q2 2018, worth a combined $43.1B — down 14% from $49.9B a quarter earlier.
Sellers outnumbered buyers: 125 funds closed out of CELG and 100 opened new positions — a net loss of 25 holders — while 651 trimmed existing stakes and 443 added.
The largest buyer was HBK Investments, opening a new position worth an estimated $1.29B. The largest seller was Eaton Vance Management, cutting an estimated $342M.
- 1,360 institutional investors held Celgene Corp (CELG) as of Q2 2018, down from 1,397 in Q1 2018.
- Funds reported $43.1B of Celgene Corp stock for Q2 2018, down 14% quarter-over-quarter.
- 100 funds opened new Celgene Corp positions in Q2 2018 and 125 closed out, a net change of -25 holders.
- The largest Celgene Corp buyer in Q2 2018 was HBK Investments, an estimated $1.29B added.
- The largest Celgene Corp seller in Q2 2018 was Eaton Vance Management, an estimated $342M sold.
Based on aggregated 13F filings for Q2 2018.